More than Just a Life Support,
We Restore What Life is Meant To Be.
We are dedicated to addressing the unmet health care needs of patients suffering from cardiovascular diseases.
More than Just a Life Support,
We Restore What Life is Meant To Be.
We are dedicated to addressing the unmet health care needs of patients suffering from cardiovascular diseases.
ANIVIA SG1000 Pump Console
The SG1000 Pump Console is a key component of the Anivia System, designed to drive disposable centrifugal pump heads in extracorporeal blood circuits. Its open-system architecture allows for interoperability with various disposable brands, offering flexible configurations to meet diverse clinical demands.
Hengqin, China — August 25, 2025
KYHT (Zhuhai) Biotech Co., Ltd. (“KYHT”), our China subsidiary, has received registration approval from China’s National Medical Products Administration (NMPA) for its proprietary cardiopulmonary centrifugal pump and control system. This milestone marks our entry into China’s high-end extracorporeal circulation equipment market and underscores the company’s progress from clinical innovation to demonstrated engineering and quality execution.
Technology Ownership and Innovation
KYHT’s cardiopulmonary centrifugal pump and control system integrate advanced fluid dynamics principles to achieve low hemolysis and stable, long-duration operation. NMPA registration affirms the strength of domestic innovation in China’s medical-equipment sector and provides clinicians with more accessible and effective options.
Clinical Value and Use Cases
Designed to serve as the base platform for our selective hypothermia therapy program*, the cardiopulmonary centrifugal pump and control system also function as critical systems for cardiopulmonary support procedures. They play life-saving roles in cardiac surgery, intensive care, and emergency transport.
Designed for China’s Clinical Environment
Key features include:
Henry Lin, Chief Executive Officer, said: “NMPA registration is a strong endorsement of our product’s technology and clinical value, and it enables us to deliver safe, reliable equipment to the market with high standards of quality. Looking ahead, we will continue to advance innovative products that bring high-end medical equipment and therapy to China.”
* The selective hypothermia therapy described above remains investigational and is not approved for commercial use.
May 6-10, 2025
Anivia Medical exhibited at the Sanibel Conference for the third year in a row, May 6 – 10, 2025, in beautiful Florida. Our team was energized by many insightful conversations with those who stopped to discuss the SG1000 pump console system. Clinicians overwhelmingly indicated that the SG1000 compact design for easy transport and the advanced touch screen display were important features that make a difference in their clinical practice. Thank you to the Sanibel Planning Team who orchestrated a top-notch conference! Anivia Medical looks forward to participating again in 2026.

For more information, please contact us.